Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 250 mg - tablet, film coated - excipient ingredients: crospovidone; silicon dioxide; copovidone; sodium stearylfumarate; microcrystalline cellulose; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.,efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,famciclovir is also indicated for suppression of recurrent genital herpes.,famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 125 mg - tablet, film coated - excipient ingredients: silicon dioxide; microcrystalline cellulose; sodium stearylfumarate; copovidone; crospovidone; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.,efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,famciclovir is also indicated for suppression of recurrent genital herpes.,famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: sodium stearylfumarate; silicon dioxide; crospovidone; copovidone; microcrystalline cellulose; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.,efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,famciclovir is also indicated for suppression of recurrent genital herpes.,famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 125 mg - tablet, film coated - excipient ingredients: sodium stearylfumarate; crospovidone; silicon dioxide; copovidone; microcrystalline cellulose; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.,efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,famciclovir is also indicated for suppression of recurrent genital herpes.,famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: sodium stearylfumarate; crospovidone; microcrystalline cellulose; silicon dioxide; copovidone; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.,efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,famciclovir is also indicated for suppression of recurrent genital herpes.,famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 250 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; silicon dioxide; sodium stearylfumarate; copovidone; crospovidone; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.,efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,famciclovir is also indicated for suppression of recurrent genital herpes.,famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 250 mg - tablet, film coated - excipient ingredients: copovidone; crospovidone; sodium stearylfumarate; silicon dioxide; microcrystalline cellulose; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.,efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,famciclovir is also indicated for suppression of recurrent genital herpes.,famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: silicon dioxide; copovidone; microcrystalline cellulose; sodium stearylfumarate; crospovidone; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.,efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,famciclovir is also indicated for suppression of recurrent genital herpes.,famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - famciclovir -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - famciclovir -